皇家飞利浦 PHG

Effective October 15, 2022, Roy Jakobs was appointed as CEO of the company. Roy joined Philips in 2010 and has held various global leadership positions across the company, starting as Chief Marketing & Strategy Officer for Philips Lighting. In 2012, he became Market Leader for Philips Middle East & Turkey, leading the Healthcare, Consumer, and Lighting businesses out of Dubai. Subsequently, he became global Business Leader of Domestic Appliances, based in Shanghai, in 2015. In 2018, Roy joined the Executive Committee as Chief Business Leader of Personal Health and in early 2020 he started as Chief Business Leader of Connected Care. As Chief Executive Officer and Chairman of the Board of Management and the Executive Committee, he also holds direct responsibility for Patient Safety and Quality, Medical Office, and Internal Audit. Prior to his career at Philips, he held various management positions at Royal Dutch Shell and RELX.

Mr. Marnix Van Ginneken joined Philips in 2007 and became Chief Legal Officer of Royal Philips and member of the Executive Committee in 2014. In 2017 he was appointed to the Board of Management. He is responsible for driving ESG efforts across the company, including Group Sustainability. He is also responsible for Legal, Intellectual Property & Standards and Government and Public Affairs. Since January 1, 2024, he is Chairman of the Board of the Philips Foundation. In 2011, he was appointed Professor of International Corporate Governance at the Erasmus School of Law in Rotterdam. Before joining Philips, Marnix worked for Akzo Nobel and as an attorney in a private practice.

Ms. Charlotte Hanneman, Executive Vice President, Chief Financial Officer and Member of the Board of Management, since October 1, 2024. Charlotte joined Philips in 2024 and is responsible for Finance, including Investor Relations, Strategy and M&A, as well as Real Estate and Security. Prior to joining Philips, Charlotte served as Controller and Head of Financial Planning & Analysis at global medical technology company Stryker. In this role, she was responsible for external reporting, enterprise financial planning and analysis, and business development finance. She also oversaw indirect procurement and had direct responsibility for finance teams across Europe, the Middle East and Africa, Canada, and Latin America. Earlier in her career, Charlotte held several international finance leadership roles at Stryker and other multinational healthcare companies, including Merck, Schering-Plough and Organon. She has extensive experience working in the US and has lived in multiple countries across Asia and Europe.

Mr. Feike Sijbesma, Chairman of the Supervisory Board since May 2021 and Member of the Supervisory Board since 2020. He is former CEO of Koninklijke DSM NV (Honorary Chairman) and former non-executive Director of Unilever NV. Co-Chair of the Global Climate Adaptation Center and Member of the Board of Trustees of the World Economic Forum.

Mr. Peter Loscher, is Member of the Supervisory Board, since 2020. He is former President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co., President and CEO of GE Healthcare Bio-Sciences and member of GE's Corporate Executive Council, CEO and Delegate of the Board of Directors of Renova Management AG. Currently member of the Board of Directors of Telefonica S.A. and CaixaBank S.A. and Chairman of the Supervisory Board of Telefonica Deutschland Holding AG, Non-Executive Director of Thyssen-Bornemisza Group AG

Herna Verhagen, is Member of the Supervisory Board, since 2022. She is former CEO of PostNL, member of the Supervisory Board of Het Concertgebouw N.V. and member of the Advisory Board of Goldschmeding Foundation. Currently member of the Supervisory Board of ING Groep N.V.

Ms. Elizabeth Doherty, is Member of the Supervisory Board, since 2019. She is currently, member of the Supervisory Board and Chairwoman of the audit committee of Novartis AG and of Corbion N.V. Member of the advisory committee of Freya Holdco S.a r.l. Fellow of the Chartered Institute of Management Accountants. Former CFO and board member of Reckitt Benckiser Group PLC, former CFO of Brambles Ltd, former non-executive director and audit committee member at Delhaize Group, Nokia Corp., SABMiller PLC and Dunelm Group PLC. Former non-executive board member of the UK Ministry of Justice and of Her Majesty's Courts and Tribunals Service (UK) and advisor to GBfoods SA and Affinity Petcare SA (subsidiaries of Agrolimen SA).

Sanjay Poonen, is Member of the Supervisory Board, since 2022. He is former Chief Operating Officer at VMware and President at SAP. Currently CEO and President of Cohesity and member of the Board of Directors of Snyk.

Chua Sock Koong, is Member of the Supervisory Board, since 2021. She is Former Group CEO of Singapore Telecommunications Limited and currently member of the Board of Directors of Prudential plc, Bharti Airtel Limited, Bharti Telecom Limited and Ayala Corporation. Member of the Council of Presidential Advisors of Singapore, the Securities Industry Council and the Dubai Financial Services Authority, Deputy Chairman of the Public Service Commission of Singapore.

Mr. Marc Harrison, is Member of the Supervisory Board, since 2018. He is former President and Chief Executive Officer of Intermountain Healthcare and former Chief of International Business Development for Cleveland Clinic and Chief Executive Officer of Cleveland Clinic Abu Dhabi. Currently CEO HATCo (Health Assurance Transformation Company) at General Catalyst.

Ms. Indra Nooyi, is Member of the Supervisory Board, since 2021. She is former CFO, President, Chairman and CEO of PepsiCo. Currently member of the Board of Directors and Chair of the Audit Committee of Amazon, Inc. and member of the Board of Directors of Honeywell Inc. Member of the Board of Trustees of the Memorial Sloan Kettering Hospital, trustee of the National Gallery of Art.

Robert White was appointed as a Member of the Supervisory Board with effect from the 2025 AGM on May 8th, 2025. Former Executive Vice President and President at Medtronic plc, Senior Vice President at Chemdex Corporation, Accelrys Inc., SourceOne Healthcare Technologies, Inc., GE Healthcare Technologies Inc. (leading the Diagnostic Imaging business) and Covidien plc (President for Emerging Markets and President for Respiratory and Monitoring Solutions). He also formerly held board positions as non-executive member of the public board of Smith & Nephew plc. Currently Director, Representative Executive Officer, President and Chief Executive Officer of Olympus Corporation.

Ling Liu (Chief Greater China Region) has been appointed as new member of the Executive Committee, effective July 1, 2024. Ling joined Philips in 1998 and has more than 26 years' experience in leadership roles in Greater China, the Netherlands and North America.

Jeff DiLullo, Executive Vice President and Chief Region Leader, Philips North America. Jeff joined Philips in 2019, drawing on more than 30 years of leadership experience in the US Army and the information technology industry.

Shez Partovi, Executive Vice President, Chief Innovation Officer and Chief Business Leader, Enterprise Informatics. Shez joined Philips in 2021, bringing over 30 years of clinical (neuroradiology) and healthcare informatics experience, including cloud transformation, machine learning, and AI.

Willem Appelo, Executive Vice President and Chief Operations Officer. Wim joined Philips in 2022, bringing over 30 years of experience in technology and the medical device technology industry in finance and supply chain management.

Heidi Sichien, Executive Vice President and Chief People Officer. Heidi joined Philips in 2006 and brings over 19 years of experience in leadership roles in HR across many parts of the company.

Ozlem Fidanci, Executive Vice President and Chief of International Region. Ozlem rejoined in 2025 and has been with Philips more than 27 years. She has extensive expertise and proven leadership across multiple geographies in both the health systems and personal health domains.

Bert van Meurs, Executive Vice President and Chief Business Leader, Diagnosis and Treatment. Bert joined Philips in 1985 and has more than 40 years of experience in the medical imaging interventional and healthcare business.

Steve C de Baca, Executive Vice President and Chief Patient Safety and Quality Officer. Steve joined Philips in 2023 and brings over 30 years of quality and regulatory affairs experience in the medical technology industry.